Excellence is just the beginning.


French German Italian Portuguese Russian

Chemotherapy — Clinical Trials

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study

A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer.

Drug Treatment Study for Patients with Triple Negative Breast Cancer

A randomized, double-blind, phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple-negative breast cancer followed by adjuvant continuation of atezolizumab or placebo.

Glioblastoma Drug Treatment Study

A phase II/III randomized trial of veliparib or placebo In combination with adjuvant temozolomide In newly diagnosed glioblastoma with MGMT promoter hypermethylation.

HER2-Positive Locally Advanced/Metastatic Breast Cancer Treatment Study

A randomized, multicenter, open label study of MM-302 plus trastuzumab vs. chemotherapy of physician's choice plus trastuzumab in anthracycline naive patients with locally advanced/metastatic HER2-positive breast cancer.

Non-Rhabdomyosarcoma Soft Tissue Sarcomas Treatment Study

Pazopanib neoadjuvant trial in non-rhabdomyosarcoma soft tissue sarcomas (PAZNTIS): A phase II/III randomized trial of preoperative chemoradiation or preoperative radiation plus or minus pPazopanib.

Proton or Photon RT for Retroperitoneal Sarcomas Study

Phase I/II trial of pre-operative image guided intensity modulated proton radiation therapy (IMPT) or photon (IMRT) with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.

Study Assessing the Accuracy of Tumor Biopsies After Chemotherapy

Assessing the accuracy of tumor biopsies after chemotherapy to determine if patients can avoid breast surgery.

The Role of suPAR in Doxorubicin Induced Cardiomyopathy in Breast Cancer Patients

SuPAR: The role of suPAR in doxorubicin induced cardiomyopathy in breast cancer patients: Causative vs. predictor.

Treatment Study for Patients with Prostate Cancer

Phase II-III trial of adjuvant radiotherapy following radical prostatectomy with or without adjuvant docetaxel.

Treatment Study for Patients with Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Metformin hydrochloride and combination chemotherapy in treating patients with stage III-IV ovarian, fallopian tube, or primary peritoneal cancer.